🇺🇸 FDA
Pipeline program

Envafolimab

HMPL-013-E1-GC003

Phase 2 small_molecule active

Quick answer

Envafolimab for Gastric Cancer is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Gastric Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials